A5028459404- Transgenic Plants and Applications
- Clostridium difficile and Clostridium perfringens research
- Gut microbiota and health
- Probiotics and Fermented Foods
- Biosimilars and Bioanalytical Methods
- CRISPR and Genetic Engineering
- Digestive system and related health
- Viral gastroenteritis research and epidemiology
Recent developments in the understanding of relationship between microbiota and its host have provided evidence regarding therapeutic potential selected microorganisms to prevent or treat disease. According Directive 2001/83/EC, European Union (EU), any product intended disease is defined as a medicinal requires marketing authorization by competent authorities prior commercialization. Even if pharmaceutical regulatory framework harmonized at EU level, obtaining authorisations for products...
During the last decade, a plethora of novel therapies containing live microorganisms as active substance(s) has emerged with aim to treat, prevent, or cure diseases in human beings. Both Food and Drug Administration (FDA) European Directorate for Quality Medicines Health Care (EDQM) codified these biotherapies Live Biotherapeutic Products (LBPs). While innovative products offer healthcare opportunities, they also represent challenge developers who need set most suitable designs non-clinical...